Navigation Links
Terumo To Simultaneously Evaluate Misago Self-Expanding Stent System in the United States and Japan
Date:5/12/2010

SOMERSET, N.J., May 12 /PRNewswire/ -- Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation, today announced it has received an investigational device exemption (IDE) conditional approval from the U.S. Food & Drug Administration (FDA) for its Occlusive/Stenotic Peripheral Artery Revascularization Study (OSPREY) in the U.S., which will evaluate the safety and effectiveness of the MISAGO™ Self-expanding Stent System for use in the superficial femoral artery (SFA).  This marks the company's first U.S. clinical trial for a premarket approval (PMA) device.  A unique feature of the clinical trial is that it will simultaneously enroll patients in the U.S. and Japan.  Referred to as  "Medical Device Collaborative Consultation and Review of Premarketing Applications" under the larger "Harmonization by Doing" (HBD) initiative, Terumo's trial was selected as one of two projects to pilot this approach, which is intended to shorten the gap between product approvals in these two significant world healthcare markets.

(Logo: http://www.newscom.com/cgi-bin/prnh/20100512/NY03471LOGO )

HBD is an international effort to develop global clinical trials and address regulatory barriers that may be impediments to timely device approvals.  This process is a cooperative effort to move both Japan and the U.S. toward international regulatory harmonization.  The HBD initiative is a pilot project launched in December 2003 that seeks regulatory converg
'/>"/>

SOURCE Terumo Interventional Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
2. Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
3. Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants
4. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
5. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
6. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
7. Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System
8. Terumo to Sponsor Presentations on Key Issues in Cardiac and Vascular Surgery at Society of Thoracic Surgeons Annual Meeting
9. New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy
10. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
11. Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  PTC Therapeutics, Inc. (NASDAQ: ... will host a webcast conference call to report its ... on the company,s business and outlook on Thursday, August ... of the market. The call can ... 935-8152 (international) five minutes prior to the start of ...
(Date:7/24/2014)... , July 24, 2014  Restore Health, ... and compounded pharmaceuticals, announced that it is now ... unique to each individual based upon their particular ... by understanding the interaction between a patient,s genetics ... "We,re very excited to provide this new service ...
(Date:7/24/2014)... Deutschland, und MARSEILLE , ... , Weltweite Exklusivlizenz der ... QIAGEN die Entwicklung von Tests auf SF3B1-Mutationen, ... Neuer Test weist Mutationen des ... (myelodysplastischen Syndromen) einen günstigen Krankheitsverlauf vermuten lassen  ...
Breaking Medicine Technology:Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 2Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5
(Date:7/24/2014)... 2014 CarePoint Health is proud ... and oncology, Dr. Hitendra Upadhyaya, has joined our ... Dr. Upadhyaya to the community. Hundreds of highly ... Group, a comprehensive network of top doctors and ... of specialties. This latest acquisition represents CarePoint Health’s ...
(Date:7/24/2014)... HealthDay Reporter THURSDAY, July 24, 2014 ... their kids as unhealthy or recognize the health consequences of ... The children of the families surveyed for the new research ... in Providence, R.I. "A third categorized their child,s health ... Rhee, now an assistant professor of pediatrics at the University ...
(Date:7/24/2014)... increase the risk for head and neck cancer (HNC). Evidence ... but the risk of HNC in patients with DM has ... the sixth most common type of cancer. It accounts for ... 650,000 new cancer cases and 350,000 cancer deaths worldwide each ... Database to examine the risk of HNC in patients with ...
(Date:7/24/2014)... 2014 Pools and beaches are the place ... be dangerous, especially for small children, so Amica Insurance ... According to the Centers for Disease Control and Prevention, children ... risk for water-related injuries and deaths. It’s important to know ... so Amica is offering the following tips from the American ...
(Date:7/24/2014)... may have found a way to delay or even ... neurons with the anti-aging protein Klotho can prevent neuron ... and glutamate. These findings currently appear in the ... is the most frequent age-related dementia affecting 5.4 million ... older and more than 40 percent of people over ...
Breaking Medicine News(10 mins):Health News:Dr. Upadhyaya Joins CarePoint Health Medical Group 2Health News:Parents of Obese Kids Often View Them as Healthy 2Health News:Parents of Obese Kids Often View Them as Healthy 3Health News:Keep Kids Safe in the Water with 5 Tips from Amica 2Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2
... Batesville,Holdings, Inc., a wholly owned subsidiary ... in conjunction with Hillenbrand,s plans to separate ... announced the,appointment of Cynthia L. Lucchese as ... Batesville Holdings, Inc., Batesville Holdings, Inc., ...
... WALTHAM, Mass., Jan. 21 Thermo Fisher,Scientific Inc. (NYSE: ... financial,results for the fourth quarter of 2007 before the ... a conference call on the same,day at 9:00 a.m. ... discuss its fourth quarter financial,performance as well as future ...
... exercise choices may lower risk by almost 80 percent for those ... ... In the wake of New Year,resolutions and American waistlines bulging ever ... in,preventing couples from conceiving., Reproductive specialists say that January is ...
... New Companion Animal ... Veterinarians, OMAHA, Neb., Jan. 21 Meridian ... companion animal veterinary medicine,channel in 2008 with a ... The products, available exclusively through veterinarians,include pharmaceuticals, therapeutics, ...
... But fast food is no friend of the waistline, new study ... whether you eat out, it,s where you choose ... who live in neighborhoods with more fast-food restaurants are more likely ... restaurants, the study found. , "A lot of people have ...
... Key ... the Association, PLEASANT HILL, Calif., Jan. 21 The Mt. ... and founder, Trainer Communications, to its Corporate Executive,Board of Directors. She ... in the middle of a major capital fundraising campaign to rebuild ...
Cached Medicine News:Health News:Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer 2Health News:Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer 3Health News:Batesville Holdings, Inc., Appoints Cynthia L. Lucchese Senior Vice President and Chief Financial Officer 4Health News:Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, February 06, 2008 2Health News:Fertility Experts: Winter Waistlines a Swelling Problem for Indianians Trying to Get Pregnant 2Health News:Fertility Experts: Winter Waistlines a Swelling Problem for Indianians Trying to Get Pregnant 3Health News:New Company Enters Companion Animal Veterinary Medicine Channel 2Health News:Eating Out Doesn't Guarantee Weight Gain 2Health News:Eating Out Doesn't Guarantee Weight Gain 3Health News:Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board 2Health News:Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board 3Health News:Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board 4
Lyphochek Hemoglobin A2 Control is a human whole blood based product designed to monitor the performance of automated and manual procedures for the measurement of hemoglobin variants, including Hemog...
... Liquichek Hematology-16 Control ... use on most hematology ... to 16 parameters and ... differentials. This trilevel control ...
Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
... Amplichek CT/GC Controls are liquid ... precision of test procedures that ... gonorrhoeae. Since they are specimen ... with either urine or endocervical/urethral ...
Medicine Products: